Neuberger Berman Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Neuberger Berman Group’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-893,985	Closed	-$17.8M	–	1915
2023 Q1	$17.8M	Buy	893,985 +39,062	+5%	+$675K	0.02%	645
2022 Q4	$11.6M	Sell	854,923 -4,619	-0.5%	-$64.3K	0.01%	719
2022 Q3	$11.9M	Buy	859,542 +52,815	+7%	+$784K	0.01%	701
2022 Q2	$11.6M	Buy	806,727 +230	+0%	+$3.99K	0.01%	721
2022 Q1	$18.2M	Buy	806,497 +65,351	+9%	+$1.27M	0.02%	690
2021 Q4	$13.8M	Buy	741,146 +386,790	+109%	+$10.3M	0.01%	770
2021 Q3	$11.6M	Buy	+354,356	New	+$13.2M	0.01%	786
2017 Q2	–	Sell	-30,000	Closed	-$848K	–	1670
2017 Q1	$848K	Buy	30,000 +4,000	+15%	+$106K	﹤0.01%	1184
2016 Q4	$629K	Buy	+26,000	New	+$638K	﹤0.01%	1241
2014 Q1	–	Sell	-6,811	Closed	-$234K	–	1677
2013 Q4	$234K	Buy	+6,811	New	+$198K	﹤0.01%	1494

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group's CSII Position: Q2 2023 in Review

Neuberger Berman Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 893,985 shares — an estimated $17.8M sold.

Neuberger Berman Group first reported a position in CSII in Q4 2013 and held it in 10 quarters. The position peaked at $18.2M in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Neuberger Berman Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Neuberger Berman Group sold 893,985 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $17.8M.
Neuberger Berman Group first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 10 quarters.
Neuberger Berman Group's Cardiovascular Systems, Inc. position peaked at $18.2M in Q1 2022.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Neuberger Berman Group's 13F filing for Q2 2023, filed 11 Aug 2023.